Evidence map›Paper›PMID 36374073›Full record

ArticleAntimicrobial agents and chemotherapy2022

João Nobrega de Almeida, Cristina Jimenez-Ortigosa, Elaine Cristina Francisco, Arnaldo L Colombo, David S Perlin

Open access · greenAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

João Nobrega de AlmeidaCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.ORCID 0000-0002-3766-026X
Cristina Jimenez-OrtigosaCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.ORCID 0000-0003-0819-1668
Elaine Cristina FranciscoSpecial Mycology Laboratory, Escola Paulista de Medicina, Federal University of São Paulo, São Paulo, Brazil.ORCID 0000-0002-5530-1332
Arnaldo L ColomboSpecial Mycology Laboratory, Escola Paulista de Medicina, Federal University of São Paulo, São Paulo, Brazil.ORCID 0000-0003-0793-8491
David S PerlinCenter for Discovery and Innovation, Hackensack Meridian Health, Nutley, New Jersey, USA.ORCID 0000-0002-9503-3184
Hackensack Meridian Health · USUniversidade Federal de São Paulo · BRHospital Israelita Albert Einstein · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We analyzed a cohort of Trichosporon asahii strains with different MICs of fluconazole and voriconazole and evaluated the presence of

Indexed as

AzolesCytochrome P-450 Enzyme SystemTrichosporonAntifungal AgentsBasidiomycotaDrug Resistance, FungalFluconazoleMicrobial Sensitivity TestsSaccharomyces cerevisiaeVoriconazoleAntifungal AgentsAzolesCytochrome P-450 Enzyme SystemFluconazoleVoriconazole14-alpha-demethylaseantifungal resistanceERG11mutationsTrichosporon asahii

Identifiers

PMID36374073
PMCPMC9765002
OpenAlexW4308957881

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.